SYSTM Wealth Solutions LLC decreased its position in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 1.9% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 7,152 shares of the medical equipment provider’s stock after selling 137 shares during the quarter. SYSTM Wealth Solutions LLC’s holdings in Align Technology were worth $1,727,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently added to or reduced their stakes in the company. Parnassus Investments LLC increased its position in Align Technology by 11.3% during the fourth quarter. Parnassus Investments LLC now owns 396,603 shares of the medical equipment provider’s stock worth $108,669,000 after buying an additional 40,406 shares during the period. Achmea Investment Management B.V. increased its holdings in shares of Align Technology by 3.4% in the second quarter. Achmea Investment Management B.V. now owns 10,335 shares of the medical equipment provider’s stock valued at $2,495,000 after purchasing an additional 339 shares during the period. Tidal Investments LLC increased its holdings in shares of Align Technology by 122.9% in the first quarter. Tidal Investments LLC now owns 4,408 shares of the medical equipment provider’s stock valued at $1,445,000 after purchasing an additional 2,430 shares during the period. Nomura Holdings Inc. acquired a new position in shares of Align Technology in the fourth quarter valued at approximately $1,197,000. Finally, Norden Group LLC increased its holdings in shares of Align Technology by 3,647.7% in the first quarter. Norden Group LLC now owns 36,540 shares of the medical equipment provider’s stock valued at $11,982,000 after purchasing an additional 35,565 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.
Insiders Place Their Bets
In other news, Director C Raymond Larkin, Jr. bought 6,500 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were bought at an average cost of $235.33 per share, for a total transaction of $1,529,645.00. Following the completion of the transaction, the director now owns 28,247 shares in the company, valued at $6,647,366.51. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.62% of the stock is owned by company insiders.
Analysts Set New Price Targets
Read Our Latest Stock Report on Align Technology
Align Technology Stock Performance
ALGN opened at $253.16 on Wednesday. The business’s fifty day moving average is $232.21 and its two-hundred day moving average is $265.38. The company has a market cap of $19.06 billion, a price-to-earnings ratio of 41.71, a PEG ratio of 5.13 and a beta of 1.64. Align Technology, Inc. has a one year low of $176.34 and a one year high of $335.40.
Align Technology (NASDAQ:ALGN – Get Free Report) last posted its earnings results on Wednesday, July 24th. The medical equipment provider reported $2.41 EPS for the quarter, topping analysts’ consensus estimates of $2.32 by $0.09. The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.04 billion. Align Technology had a return on equity of 14.07% and a net margin of 11.34%. Align Technology’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.73 earnings per share. On average, analysts predict that Align Technology, Inc. will post 7.61 EPS for the current fiscal year.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Featured Stories
- Five stocks we like better than Align Technology
- Buy P&G Now, Before It Sets A New All-Time High
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- CD Calculator: Certificate of Deposit Calculator
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.